These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 9697742)

  • 1. A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod.
    Tyring SK; Arany I; Stanley MA; Tomai MA; Miller RL; Smith MH; McDermott DJ; Slade HB
    J Infect Dis; 1998 Aug; 178(2):551-5. PubMed ID: 9697742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5%.
    Arany I; Tyring SK; Stanley MA; Tomai MA; Miller RL; Smith MH; McDermott DJ; Slade HB
    Antiviral Res; 1999 Aug; 43(1):55-63. PubMed ID: 10480263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations.
    Sauder DN; Skinner RB; Fox TL; Owens ML
    Sex Transm Dis; 2003 Feb; 30(2):124-8. PubMed ID: 12567169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanisms of imiquimod indirect antiviral activity].
    Hober D; Ajram L; Chehadeh W; Lazrek M; Goffard A; Dewilde A; Wattré P
    Ann Biol Clin (Paris); 2005; 63(2):155-63. PubMed ID: 15771973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Closing the feedback loop: an audit of the use of imiquimod for the treatment of genital warts.
    Brady S; Wilson JD
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):314-7. PubMed ID: 15096142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia.
    Sanclemente G; Herrera S; Tyring SK; Rady PL; Zuleta JJ; Correa LA; He Q; Wolff JC
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1054-60. PubMed ID: 17714124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
    Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA
    Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of imiquimod in anogenital warts from HIV-positive men.
    Herrera S; Correa LA; Wolff JC; Gaviria A; Tyring SK; Sanclemente G
    J Clin Virol; 2007 Jul; 39(3):210-4. PubMed ID: 17513167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of imiquimod for the therapy of external genital and anal warts in comparison with destructive therapies.
    Schöfer H
    Br J Dermatol; 2007 Dec; 157 Suppl 2():52-5. PubMed ID: 18067633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of genital warts with an immune-response modifier (imiquimod).
    Beutner KR; Spruance SL; Hougham AJ; Fox TL; Owens ML; Douglas JM
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):230-9. PubMed ID: 9486679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts.
    Beutner KR; Tyring SK; Trofatter KF; Douglas JM; Spruance S; Owens ML; Fox TL; Hougham AJ; Schmitt KA
    Antimicrob Agents Chemother; 1998 Apr; 42(4):789-94. PubMed ID: 9559784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using imiquimod for genital warts in female patients.
    Cox JT; Petry KU; Rylander E; Roy M
    J Womens Health (Larchmt); 2004 Apr; 13(3):265-71. PubMed ID: 15130255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.
    Saiag P; Bauhofer A; Bouscarat F; Aquilina C; Ortonne JP; Dupin N; Mougin C
    Br J Dermatol; 2009 Oct; 161(4):904-9. PubMed ID: 19466962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day.
    Fife KH; Ferenczy A; Douglas JM; Brown DR; Smith M; Owens ML;
    Sex Transm Dis; 2001 Apr; 28(4):226-31. PubMed ID: 11318254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical imiquimod 5% cream in external anogenital warts: a randomized, double-blind, placebo-controlled study.
    Arican O; Guneri F; Bilgic K; Karaoglu A
    J Dermatol; 2004 Aug; 31(8):627-31. PubMed ID: 15492435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, efficacy & recurrence rates of imiquimod cream 5% for treatment of anogenital warts.
    Diamantis ML; Bartlett BL; Tyring SK
    Skin Therapy Lett; 2009 Jun; 14(5):1-3, 5. PubMed ID: 19609471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sinecatechins and imiquimod as proactive sequential therapy of external genital and perianal warts in adults.
    Schöfer H; Tatti S; Lynde CW; Skerlev M; Hercogová J; Rotaru M; Ballesteros J; Calzavara-Pinton P
    Int J STD AIDS; 2017 Dec; 28(14):1433-1443. PubMed ID: 28566057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open-label phase II pilot study investigating the optimal duration of imiquimod 5% cream for the treatment of external genital warts in women.
    Garland SM; Waddell R; Mindel A; Denham IM; McCloskey JC
    Int J STD AIDS; 2006 Jul; 17(7):448-52. PubMed ID: 16820073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imiquimod: an immune response modifier.
    Dahl MV
    J Am Acad Dermatol; 2000 Jul; 43(1 Pt 2):S1-5. PubMed ID: 10861100
    [No Abstract]   [Full Text] [Related]  

  • 20. Topical imiquimod cream 5% for resistant perianal warts in a renal transplant patient.
    Gayed SL
    Int J STD AIDS; 2002 May; 13(5):349-51. PubMed ID: 11972940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.